Carbazochrome
-
Carbazochrome
structure -
-
CAS No:
69-81-8
-
Formula:
C10H12N4O3
-
Chemical Name:
Carbazochrome
-
Synonyms:
Hydrazinecarboxamide,2-(1,2,3,6-tetrahydro-3-hydroxy-1-methyl-6-oxo-5H-indol-5-ylidene)-;Adrenochrome semicarbazone;5,6-Indolinedione,3-hydroxy-1-methyl-,5-semicarbazone;2-(1,2,3,6-Tetrahydro-3-hydroxy-1-methyl-6-oxo-5H-indol-5-ylidene)hydrazinecarboxamide;Adrenoxyl;Carbazochrome;Adrenostazin;Adrokson;Adroxon;Sangostazin;3-Hydroxy-1-methyl-5,6-indolindione 5-semicarbazone;Adchnon;Cromadrenal;Adedolon;Adrezon;Sangostasin;Carbazochrom;Cartabes;Adrenochrome monosemicarbazone;Cromosil;NSC 73742;2-(3-Hydroxy-1-methyl-6-oxo-2,3-dihydro-1H-indol-5(6H)-ylidene)hydrazinecarboxamide;51055-36-8
- Categories:
-
CAS No:
Description
Carbazochrome is a member of indoles. It derives from a semicarbazide.|Carbazochrome is a hemostatic agent that promotes clotting, preventing blood loss from open wounds. It is an oxidation product of adrenaline which enhances the microcirculatory tone. In the future this may prevent excessive blood flow during surgical operations and the treatment of hemorrhoids, but research on effectiveness and severity of side effects remains inconclusive. It is not FDA-approved but is available as tablets or IM/SC injections in the treatment of hemorrhages in a number of countries. Carbazochrome has been investigated for use in the treatment of non-surgical acute uncomplicated hemorrhoids in a mixture with [DB13124], and this combination therapy demonstrated efficacy and safe tolerability either at a local or systemic level.
Carbazochrome Basic Attributes
236.23
236.23
200-717-0
73742
DTXSID3048310
B - Blood and blood forming organs
2933990090
Characteristics
112
-0.26090
nacarat crystalline powder
1.6±0.1 g/cm3
212-213 °C (decomp)
1.733
−20°C
Drug Information
Indicated for capillary and parenchymal hemorrhage (trauma, tonsillectomy, during surgery), intestinal bleeding, and thrombocytopenic purpura.
Carbazochrome is an anti-bleeding agent that increases platelet aggregation and forms a platelet plug by interacting with α-adrenoreceptors on surface of platelets. It is shown to improve the structure of local capillary vessels in haemorrhage caused by fragility of capillaries. Carbazochrome capillary stabilizer that reverses pulmonary vascular hyperpermeability and decreases arterial PaO2 in experimental models.
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)
Carbazochrome interacts with platelet surface α-adrenoreceptors which are Gq-coupled receptors that leads to activation of PLC IP3/DAG pathway and increase in intracellular calcium levels. Elevated calcium ions bind to calmodulin and activates Ca2+/calmodulin-dependent myosin light chain kinase, allowing the myosin crossbridge to bind to the actin filament and polymerisation of globular actin (G-actin) to filamentous actin (F-actin). Subsequent contraction of endothelial cells changes the shape of platelets and promotes the release of factors such as serotonin, ADP, Von Willebrand and platelet activating factor by platelets that induce aggregation and platelet adherence. Carbazochrome is reported to inhibit vascular hyperpermeability by inhibiting agonist-induced phosphoinositides hydrolysis caused by various vasoactive agents such as tryptase, thrombin and bradykinin.
AC-17
Carbazochrome Use and Manufacturing
This product can reduce the permeability of capillaries and promote the retraction of damaged capillaries to stop bleeding. Mainly used for bleeding caused by increased capillary permeability, such as idiopathic purpura, retinal hemorrhage, chronic pulmonary hemorrhage, gastrointestinal bleeding, epistaxis, hemoptysis, hematuria, hemorrhoidal bleeding, uterine bleeding, cerebral hemorrhage, etc. It is less effective for massive bleeding and arterial bleeding. Hemostatic drug, used for persistent Zipan syndrome, hereditary capillary dilation, and prevention of bleeding in the lungs, kidneys, intestines, brain, and uterus.
Pharmaceuticals -> Animal Drugs -> Approved in Taiwan
Computed Properties
Molecular Weight:236.23
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:1
Exact Mass:236.09094026
Monoisotopic Mass:236.09094026
Topological Polar Surface Area:112
Heavy Atom Count:17
Complexity:336
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Drug Function and Efficacy
It is an oxidized derivative of adrenaline and has no adrenaline-mimetic effect, so it does not affect blood pressure and heart rate, but it can enhance the resistance of capillaries to damage, stabilize the acidic mucopolysaccharides in blood vessels and surrounding tissues, reduce the permeability of capillaries, and enhance the retraction effect of damaged capillary ends, making it difficult for blood clots to fall off the tube wall, thereby shortening the hemostasis time, but it does not affect the coagulation process.
Registered Holders
-
China Resources Double-Crane Pharmaceutical Co., Ltd.
Active
China
-
Wuhan Wuyao Pharmaceutical Co., Ltd.
Active
China
-
Changzhou Yabang Pharmaceutical Co., Ltd.
Active
China
Recommended Suppliers of Carbazochrome
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Agrochemicals,Daily Chemicals,Catalysts & Chemical Auxiliary Agents,Extract,Inorganic Chemicals,Organic Intermediate,Pigment & Dyestuff,Polymer,Flavour & Fragrance,Basic Organic Chemicals,Pharmaceutical -
CN
2 YRS
Business licensedTrader Supplier of API,Antibiotics,Anti cancer category
Learn More Other Chemicals
-
Carbazochrome sodium sulfonate
51460-26-5
-
Trimethylolpropane trioleate
57675-44-2
-
Dabigatran etexilate mesylate
872728-81-9
-
Deferasirox Formula
201530-41-8
-
Argatroban Formula
74863-84-6
-
Clopidogrel Formula
113665-84-2
-
Iron(2+) succinate Structure
10030-90-7
-
Protamines Structure
9012-00-4
-
What is (±)-Acenocoumarol
152-72-7
-
What is Coagulase
9001-13-2